HomeECX • FRA
Epigenomics AG
€0.88
0.23%
+0.0020 Today
Jun 10, 2:02:35 PM UTC+2 · EUR · FRA · Disclaimer
Market news
Financials
Income Statement
-1M01M
Revenue
Net Income
Revenue
Net income
(EUR)Dec 2024Y/Y change
Revenue
Operating expense
482.00K122.92%
Net income
-1.28M-167.97%
Net profit margin
Earnings per share
EBITDA
-479.00K-120.79%
Effective tax rate
05M10M15M20M
Total Assets
Total Liabilities
Total assets
Total liabilities
(EUR)Dec 2024Y/Y change
Cash and short-term investments
927.00K-55.94%
Total assets
11.85M-7.73%
Total liabilities
11.85M-43.18%
Total equity
0.00
Shares outstanding
876.95K
Price to book
Return on assets
-10.17%
Return on capital
-10.59%
0100K200K300K400K
Net Change in Cash
Net change in cash
(EUR)Dec 2024Y/Y change
Net income
-1.28M-167.97%
Cash from operations
Cash from investing
Cash from financing
Net change in cash
Free cash flow
StockDE listed securityDE headquartered
Previous close
€0.88
Day range
€0.88 - €0.88
Year range
€0.50 - €2.30
Market cap
776.86K EUR
Avg Volume
71.00
P/E ratio
-
Dividend yield
-
Primary exchange
FRA
About
Epigenomics AG is a molecular diagnostics company headquartered in Berlin, Germany with a wholly owned subsidiary, Epigenomics Inc. based in Seattle, WA. Wikipedia
Founded
1998
Employees
2
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Main menu
Google apps